The Effects of Postoperative Residual Neuromuscular Blockade on Hospital Costs and Intensive Care Unit Admission: A Population-Based Cohort Study

Anesthesia and Analgesia

Volumn 128, Issue 6, 2019, Pages 1129-1136

  Grabitz, Stephanie D ^a   Rajaratnam, Nishan ^a   Chhagani, Khushi ^a   Thevathasan, Tharusan ^a   Teja, Bijan J ^b   Deng, Hao ^a   Eikermann, Matthias ^b,c   Kelly, Barry J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMBULATORY SURGERY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENERAL ANESTHESIA; HEALTH CARE UTILIZATION; HOSPITAL COST; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; RECOVERY ROOM; RETROSPECTIVE STUDY; SECONDARY ANALYSIS; SENSITIVITY ANALYSIS; ADVERSE EVENT; AGED; DELAYED EMERGENCE FROM ANESTHESIA; ECONOMICS; HOSPITAL ADMISSION; INTENSIVE CARE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROCEDURES; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ATRACURIUM BESILATE; CISATRACURIUM; ROCURONIUM; VECURONIUM;

ADULT; AGED; ATRACURIUM; CRITICAL CARE; DATA INTERPRETATION, STATISTICAL; DELAYED EMERGENCE FROM ANESTHESIA; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; PATIENT ADMISSION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ROCURONIUM; TREATMENT OUTCOME; VECURONIUM BROMIDE;

EID: 85066853173     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000004028     Document Type: Article

References (20)

1. McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology. 2015;122:1201-1213.
2. Thevathasan T, Shih SL, Safavi KC, et al. Association between intraoperative non-depolarising neuromuscular blocking agent dose and 30-day readmission after abdominal surgery. Br J Anaesth. 2017;119:595-605.
3. Fortier LP, McKeen D, Turner K, et al. The RECITE study: a Canadian Prospective, Multicenter Study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121:366-372.
4. Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105:304-309.
5. Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Survey Anesthesiol. 2013;57:156-157.
6. Donati F. Residual paralysis: a real problem or did we invent a new disease? Can J Anaesth. 2013;60:714-729.
7. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111:110-119.
8. Kumar GV, Nair AP, Murthy HS, Jalaja KR, Ramachandra K, Parameshwara G. Residual neuromuscular blockade affects postoperative pulmonary function. Anesthesiology. 2012;117:1234-1244.
9. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120-128.
10. Sasaki N, Meyer MJ, Malviya SA, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology. 2014;121:959-968.
11. Ladha K, Vidal Melo MF, McLean DJ, et al. Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ. 2015;351:h3646.
12. Brueckmann B, Villa-Uribe JL, Bateman BT, et al. Development and validation of a score for prediction of postoperative respiratory complications. Anesthesiology. 2013;118:1276-1285.
13. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
14. Wunsch H, Gershengorn HB, Cooke CR, et al. Use of intensive care services for Medicare beneficiaries undergoing major surgical procedures. Anesthesiology. 2016;124:899-907.
15. Kahan BC, Koulenti D, Arvaniti K, et al; The International Surgical Outcomes Study (ISOS) Group Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries. Intensive Care Med. 2017;43:971-979.
16. Thevathasan T, Copeland CC, Long DR, et al. The impact of postoperative intensive care unit admission on postoperative hospital length of stay and costs: a prespecified propensitymatched cohort study. Anesth Analg. 2018 [Epub ahead of print].
17. Dexter F, Blake JT, Penning DH, Sloan B, Chung P, Lubarsky DA. Use of linear programming to estimate impact of changes in a hospital's operating room time allocation on perioperative variable costs. Anesthesiology. 2002;96:718-724.
18. Rudolph MI, Chitilian HV, Ng PY, et al. Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications. Anaesthesia. 2018;73:1067-1078.
19. O Neill L, Dexter F. Tactical increases in operating room block time based on financial data and market growth estimates from data envelopment analysis. Anesth Analg. 2007;104:355-368.
20. Dexter F, Epstein RH. Typical savings from each minute reduction in tardy first case of the day starts. Anesth Analg. 2009;108:1262-1267.